Vilanterol

Definition: Vilanterol is an ultra-long-acting β2-adrenoceptor agonist which was approved in May 2013 in combination with fluticasone furoate for sale as Breo Ellipta by GlaxoSmithKline for the treatment of chronic obstructive pulmonary disease (COPD). The combination is also approved for the treatment of asthma in Canada, Europe, Japan and New Zealand. Vilanterol is available in following combinations: source: Wikipedia

ID

702408004

ID date

1 Oct 2014

Previous ID

23560911000001108

Name

Vilanterol